Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma

NCT01029730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Bortezomib
DRUG: Rituximab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]